The International Consensus Classification describes this condition as acute myeloid leukemia with mutated TP53, with the presence of at least 20% of blasts or meeting the criteria for pure erythroid leukemia in the blood or bone marrow accompanied by a somatic TP53 mutation with a variant allele frequency greater than 10% [2]. This evidence concerns the gene TP53 and acute myeloid leukemia.